Published in

Esmo Open, Esmo Open, 6(3), p. e000408, 2018

DOI: 10.1136/esmoopen-2018-000408

Links

Tools

Export citation

Search in Google Scholar

Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme.

Journal article published in 2018 by Colin R. Lindsay ORCID, Emily C. Shaw, Kevin G. Blyth, James D. Brenton, Noel Clarke, Anshuman Chaturvedi, Craig Dick, Phillipe Taniere, Andrew M. Hanby, Geoff Hall, David J. Harrison, Malcolm D. Mason, Stephen R. D. Johnston, Karin A. Oien, Ian Walker and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown
Data provided by SHERPA/RoMEO

Abstract

Phase I of the Cancer Research UK Stratified Medicine Programme (SMP1) was designed to roll out molecular pathology testing nationwide at the point of cancer diagnosis, as well as facilitate an infrastructure where surplus cancer tissue could be used for research. It offered a non-trial setting to examine common UK cancer genetics in a real-world context.